Position in NVO
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$35,026,113
+$5,219,218 QoQ
Shares Held
730,624
-9.9% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#66
of 1,348 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 61%
Shared 0%
None 39%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TRUIST FINANCIAL CORP holds $2,652,531,465 across 15 Drug Manufacturers - General names. NVO ranks #10 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
2,519,569 | $634,024,342 | |
| 2 | JNJ |
Johnson & Johnson
|
2,173,861 | $552,095,477 | |
| 3 | LLY |
ELI LILLY & Co
|
400,653 | $480,555,266 | |
| 4 | MRK |
Merck & Co., Inc.
|
2,308,510 | $296,643,534 | |
| 5 | NVS |
Novartis AG
|
968,701 | $151,814,820 | |
| 6 | AZN |
Astrazeneca PLC
|
797,497 | $151,221,380 | |
| 7 | AMGN |
Amgen Inc
|
394,190 | $142,744,081 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
1,277,343 | $73,600,502 |
All Filings in NVO
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $35,026,113 | 730,624 | Shares | Defined | 2026-07-28 | |
| 2026-03-31 | $29,806,895 | 811,072 | Shares | Defined | 2026-04-27 | |
| 2025-12-31 | $35,369,943 | 695,164 | Shares | Defined | 2026-02-02 | |
| 2025-09-30 | $43,323,594 | 780,746 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $45,666,944 | 661,648 | Shares | Defined | 2025-07-18 | |
| 2025-03-31 | $45,497,642 | 655,208 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $48,449,387 | 563,234 | Shares | Defined | 2025-01-31 | |
| 2024-09-30 | $68,559,909 | 575,795 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $87,409,264 | 612,367 | Shares | Defined | 2024-08-21 | |
| 2024-03-31 | $79,567,937 | 619,688 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $61,765,751 | 597,059 | Shares | Defined | 2024-02-02 | |
| 2023-09-30 | $53,437,161 | 587,609 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $48,994,192 | 302,751 | Shares | Defined | 2023-08-01 | |
| 2023-03-31 | $49,483,467 | 310,943 | Shares | Defined | 2023-05-05 | |
| 2022-12-31 | $48,433,852 | 357,868 | Shares | Defined | 2023-02-17 | |
| 2022-09-30 | $36,280,163 | 364,149 | Shares | Defined | 2022-10-26 | |
| 2022-06-30 | $40,274,477 | 361,433 | Shares | Defined | 2022-07-22 | |
| 2022-03-31 | $43,546,590 | 392,135 | Shares | Defined | 2022-04-22 | |
| 2021-12-31 | $41,668,256 | 372,038 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $35,904,569 | 373,967 | Shares | Defined | 2021-11-05 | |
| 2021-06-30 | $37,533,901 | 448,059 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $30,433,858 | 451,407 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $29,696,026 | 425,140 | Shares | Defined | 2021-11-19 | |
| 2020-09-30 | $29,007,296 | 417,792 | Shares | Defined | 2021-11-05 | |
| 2020-06-30 | $25,610,274 | 391,116 | Shares | Defined | 2021-11-16 | |
| 2020-03-31 | $29,691,601 | 493,216 | Shares | Defined | 2021-11-05 | |
| No filing history on record for this holder in this stock. | ||||||